Lawsuits are piling up from women who were injured or suffered severe side effects from a popular new intrauterine device (IUD) known as “Mirena.”
According to Steven W. Mosher of the Population Research Institute, women are being injured by a popular IUD manufactured by Bayer and marketed under the trade name “Mirena.” It is referred to as a “second generation” contraceptive because it contains levonorgestrel, a synthetic hormone that sometimes prevents ovulation.
As Mosher explains, IUDs are not really “contraceptive” devices because they act by aborting already conceived children by physically obstructing the normal process by which a baby implants in the uterus.
“Mirena, it is true, is more than just an IUD. It also contains a synthetic ‘hormone’ called levonorgestrel that some months prevents ovulation,” Mosher explains. “Even when what is called ‘breakthrough ovulation’ occurs, the progestin sometimes still prevents conception by thickening the cervical mucus and preventing sperm from reaching the ovum. Still, when this doesn’t happen, a baby can be conceived and begin its five to seven day journey down the Fallopian tube. But when it reaches the uterus itself it encounters the grim reaper in the guise of an IUD and its life is over. An early-term abortion occurs.”
Mirena also has significant and very painful side effects, such as amenorrhea, intermenstrual bleeding and spotting, abdominal pain, pelvic pain, ovarian cysts, headache, migraines, acne, depression, and mood swings.
Even more extensive damage occurs when the device dislodges and begins to migrate outside the uterus. This can cause perforation of the uterine wall, serious infections and other complications that can result in the need to have the device surgically removed.
In one lawsuit, a young woman named April Rodriquez went to her doctor to have the device removed after discovering that she was pregnant. However, the doctor couldn’t find it and it was not until she underwent an abdominal x-ray that the IUD was found to have perforated her uterine wall and lodged itself below her diaphragm. After undergoing surgery to have it removed, she miscarried.
Mirena has been around since 2000 when it was approved by the FDA. At the time, Bayer began an aggressive marketing campaign, specifically targeting busy mothers, saying it was a safe and reversible form of birth control which can prevent pregnancy for up to five years.
However, the company was later berated by the FDA for overstating the efficacy of the device and failing to inform women that they faced an unreasonable risk of problems such as spontaneous migration and uterine perforation.
But by then, Bayer had convinced more than a million American women to pay $800 for the device, which generated over a billion dollars in revenue for the company. Their sales are only expected to climb as the Obamacare birth control mandate comes into full force and requires all healthcare plans to cover devices such as Mirena with no cost to the patient.
“In other words, we taxpayers are about to make Bayer shareholders rich,” Mosher writes.
And it will all be at the expense of women’s health.
“Bayer is probably already settling lawsuits out of court as quickly and as quietly as possible, so as not to discourage other potential users of Mirena,” Mosher writes.
“When their legal costs begin to mount, their sales begin to drop, and their profit margins disappear, it will be time for their end game: this will involve taking the contraceptive off the market, at least in the U.S., and reaching a once-and-for-all settlement with the entire class of affected users.”
But don’t expect Bayer to be at all daunted by this prospect, he says.
“In fact, I believe that Bayer, like all contraceptive manufacturers, is already working on a successor contraceptive that will, in a couple of years, be released with great fanfare. . . . It will be sold by the millions. It will earn hundreds of millions for the company. It will not really be ‘new,’ however. Rather, it will closely resemble an existing contraceptive drug or device, but it will have a new name, a slightly different chemical formula, and a slightly altered appearance to preserve the fiction that it is an entirely new product.”
Like its predecessors, it will be foisted upon a new generation of women until the side effects manifest and it too is eventually pulled from the market.
Mosher reaches the grim conclusion: “What a market plan.”
Click here to read more about the dangers of Mirena.
© All Rights Reserved, Living His Life Abundantly®/Women of Grace® http://www.womenofgrace.com